Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al.

Detalles Bibliográficos
Autores principales: de Miranda Santos, Isabel Kinney Ferreira, de Barros Cardoso, Cristina Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588791/
https://www.ncbi.nlm.nih.gov/pubmed/33127564
http://dx.doi.org/10.1016/j.clim.2020.108618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588791/
https://www.ncbi.nlm.nih.gov/pubmed/33127564
http://dx.doi.org/10.1016/j.clim.2020.108618

Ejemplares similares